A. Rijneveld

AR

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2022

Affiliations

AZ Delta(Current)

A. Rijneveld is an author at AZ Delta specializing in blinatumomab therapy, b-cell targeted therapy, and molecular oncology.

Publications per year

2022–2022

1

Publications

1